Skin lightening preparations and the hydroquinone controversy
about
Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of colorAn updated review of tyrosinase inhibitorsInhibitors of melanogenesis: a patent review (2009 - 2014)Mechanisms regulating skin pigmentation: the rise and fall of complexion colorationTyrosinase inhibitors: a patent review (2011-2015)Synthesis and biological evaluation of unsymmetrical curcumin analogues as tyrosinase inhibitorsThe mechanism of action and clinical benefits of soy for the treatment of hyperpigmentationDeoxyarbutin Possesses a Potent Skin-Lightening Capacity with No Discernible Cytotoxicity against MelanosomesPhenylthiourea specifically reduces zebrafish eye sizeInfraorbital Dark Circles: A Review of the Pathogenesis, Evaluation and TreatmentComparative studies on the chemical and enzymatic stability of alpha- and beta-arbutin.Topical treatment of melasma.Hydroquinone-free Skin Brightener System for the Treatment of Moderate-to-severe Facial Hyperpigmentation.Postinflammatory hyperpigmentation: etiologic and therapeutic considerations.Vitamin C in dermatology.Acne in patients with skin of color: practical management.MITF-siRNA formulation is a safe and effective therapy for human melasmaEvidence-based treatment for melasma: expert opinion and a review.Melasma and laser treatment: an evidenced-based analysis.Facial hyperpigmentation: causes and treatment.Polypodium leucotomos as an Adjunct Treatment of Pigmentary Disorders.Melasma: clinical diagnosis and management options.Anti-melanogenic effects of black, green, and white tea extracts on immortalized melanocytesAnti-aging effects of some selected Iranian folk medicinal herbs-biochemical evidences.Hydroquinone for skin lightening: safety profile, duration of use and when should we stop?Final report of the safety assessment of Kojic acid as used in cosmetics.The melanogenesis and mechanisms of skin-lightening agents--existing and new approaches.Hydroquinone, a benzene metabolite, and leukemia: a case report and review of the literature.Natural, semisynthetic and synthetic tyrosinase inhibitors.Gomisin N Inhibits Melanogenesis through Regulating the PI3K/Akt and MAPK/ERK Signaling Pathways in MelanocytesBotanicals With Dermatologic Properties Derived From First Nations Healing.Lipoteichoic acid isolated from Lactobacillus plantarum inhibits melanogenesis in B16F10 mouse melanoma cellsTranexamic Acid in the Treatment of Melasma: A Review of the Literature.A double-blind, placebo-controlled randomized trial of Serratulae quinquefoliae folium, a new source of β-arbutin, in selected skin hyperpigmentations.Use of Skin-Whitening Products by Sudanese Undergraduate Females: a Survey.Involvement of Transient Receptor Potential Cation Channel Member A1 activation in the irritation and pain response elicited by skin-lightening reagent hydroquinone.Anti-Melanogenic Effect of Oenothera laciniata Methanol Extract in Melan-a Cells.Association of emblica, licorice and belides as an alternative to hydroquinone in the clinical treatment of melasma.Top 10 botanical ingredients in 2010 anti-aging creams.Reassessment of antioxidant activity of arbutin: multifaceted evaluation using five antioxidant assay systems.
P2860
Q24631938-66FAE2A4-79E2-4CE9-9CC6-A6462B0E7BEFQ24653671-959572C8-2D2E-4DD2-804E-86CD46BCAD68Q28261535-C49F8BAD-3E44-49FF-BF25-491EAF3A42CCQ28262877-AF324364-130B-45C4-969E-2CD77E1B12EDQ28272557-62E0CAFA-AA67-4A70-8E7D-DA175C342AE7Q28288310-1954DAA8-334E-4CCD-A874-F2F77C7176E4Q28305639-939250C3-4EBE-4F5B-B52E-E8D0D88A3488Q28552914-C454D805-347A-4AAF-802E-D81A36CB5D92Q28727943-1F375886-30E1-4F52-A349-A31800CA2F5AQ28828636-3F7D001E-EAB4-4F8C-BF41-C4B2019A0BF0Q30992355-77116E1E-F928-494D-83E5-86561A56F502Q33595442-C179E1CF-F9DE-43BB-8348-EFB9557A19F9Q33629697-C0AE9FDD-4957-45C2-BB0D-627507974BF7Q33829098-C7E2DC87-7512-4331-8524-925769110ECAQ34349077-4A8FDCF0-E830-43B2-85DC-71AC610BDAA4Q34382519-8075DFEA-3596-4983-B6FD-7FB0021659F0Q34556920-CAED4B0F-C1B1-4AA2-AB9C-E6559C03DB09Q34642576-196DB43C-5905-4ED0-AE83-B1C8DA9B6F75Q34772039-D9F98E60-CF56-4041-94ED-E5B1F7D44E70Q35010478-F0B7DF26-0FD6-4B98-BAFA-3DC0700D2926Q35136538-02113479-2911-4286-A051-F9F19E872461Q35574147-91D93F02-2531-460A-8161-61F7D7FC6807Q35790220-D279203A-12AD-4BF4-8067-99805ED29078Q37540433-AED2255E-57D6-4104-BE77-C2CDE6C6E956Q37679966-E54B8075-0541-4140-B848-512B6B02AE6FQ37821631-397ABF10-0284-4EF7-A4FE-30A8F3B39DC7Q37832277-2AB93EF9-7B88-4FCC-ABEC-E4B14A57D917Q37867857-BADD3A93-AB3B-4AD0-A08C-6E726A0DA2CCQ38356162-6C7F087F-7F4A-460B-9DAB-A09B3BFBA6C2Q38714668-82444B8B-7C87-402E-A73A-C0E19161A8EBQ38744309-32C67FFF-01AF-496B-AF10-8BF5639E2F26Q38869899-DB77E6D3-C796-4FAA-8B93-85A7764DFBF7Q39173686-DF36A059-2E0A-4E9F-BDE2-CF45FF5ECFD9Q40788852-38CB8D3A-B09B-4A5A-957E-B05B449D35F4Q40875118-D5CC0B53-1B68-41BB-B671-AA329FB78382Q41308862-71B7B97E-A312-483C-9D68-6684F233F283Q42327995-8FA13541-C619-43F9-9143-0F3A736CB355Q42779603-B4946D07-EA68-4F49-ADA3-87175B2B21FDQ42872965-5E10C538-562F-4CF3-B39A-EC2355EFB7E1Q43157776-970C56C7-A7EA-4D59-BA48-0AB5F57A509A
P2860
Skin lightening preparations and the hydroquinone controversy
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Skin lightening preparations and the hydroquinone controversy
@ast
Skin lightening preparations and the hydroquinone controversy
@en
Skin lightening preparations and the hydroquinone controversy
@nl
type
label
Skin lightening preparations and the hydroquinone controversy
@ast
Skin lightening preparations and the hydroquinone controversy
@en
Skin lightening preparations and the hydroquinone controversy
@nl
prefLabel
Skin lightening preparations and the hydroquinone controversy
@ast
Skin lightening preparations and the hydroquinone controversy
@en
Skin lightening preparations and the hydroquinone controversy
@nl
P3181
P1433
P1476
Skin lightening preparations and the hydroquinone controversy
@en
P2093
Zoe Diana Draelos
P304
P3181
P356
10.1111/J.1529-8019.2007.00144.X
P407
P577
2007-01-01T00:00:00Z